- Home
- MBOT vs SERA Comparison
MBOT vs SERA Comparison
Compare MBOT & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBOT
- SERA
- Stock Information
- Founded
- MBOT 2010
- SERA 2008
- Country
- MBOT United States
- SERA United States
- Employees
- MBOT N/A
- SERA N/A
- Industry
- MBOT Medical/Dental Instruments
- SERA Precision Instruments
- Sector
- MBOT Health Care
- SERA Health Care
- Exchange
- MBOT Nasdaq
- SERA Nasdaq
- Market Cap
- MBOT 95.4M
- SERA 85.6M
- IPO Year
- MBOT N/A
- SERA 2021
- Fundamental
- Price
- MBOT $3.85
- SERA $2.38
- Analyst Decision
- MBOT Strong Buy
- SERA
- Analyst Count
- MBOT 1
- SERA 0
- Target Price
- MBOT $9.00
- SERA N/A
- AVG Volume (30 Days)
- MBOT 2.6M
- SERA 103.4K
- Earning Date
- MBOT 08-12-2025
- SERA 08-06-2025
- Dividend Yield
- MBOT N/A
- SERA N/A
- EPS Growth
- MBOT N/A
- SERA N/A
- EPS
- MBOT N/A
- SERA N/A
- Revenue
- MBOT N/A
- SERA $108,000.00
- Revenue This Year
- MBOT N/A
- SERA $390.13
- Revenue Next Year
- MBOT $728.02
- SERA $440.54
- P/E Ratio
- MBOT N/A
- SERA N/A
- Revenue Growth
- MBOT N/A
- SERA 0.94
- 52 Week Low
- MBOT $0.82
- SERA $1.37
- 52 Week High
- MBOT $3.94
- SERA $9.13
- Technical
- Relative Strength Index (RSI)
- MBOT 76.66
- SERA 46.00
- Support Level
- MBOT $3.01
- SERA $2.17
- Resistance Level
- MBOT $3.21
- SERA $2.50
- Average True Range (ATR)
- MBOT 0.24
- SERA 0.19
- MACD
- MBOT 0.07
- SERA -0.02
- Stochastic Oscillator
- MBOT 93.08
- SERA 33.66
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.